Evidence map›Paper›PMID 21255407›Full record

ReviewVirology journal2011

Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.

Wei Liu, Sally A Huber

Abstract readReview
In one paragraph

Review in Virology journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Triggers of Inflammatory Heart Disease.Frontiers in cell and developmental biology · 2020
    Review
  7. Anti-NKG2D mAb: A New Treatment for Crohn's Disease?International journal of molecular sciences · 2017
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Update on coxsackievirus B3 myocarditis.Current opinion in rheumatology · 2012
    Review
  14. Article
  15. ERJournal of clinical & cellular immunology
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei LiuThe First Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China.
Sally A Huber

Funding

T reg Cells in MyocarditisR01HL086549 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUBER, SALLY A · 2007 to 2010
$1.5M
Sex in MyocarditisR01HL080594 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HUBER, SALLY A · 2005 to 2008
$1.2M
NHLBI NIH HHS HL80594NHLBI NIH HHS HL86549
6 · The paper itself

Abstract

CD1d is a non-classical major histocompatibility class 1-like molecule which primarily presents either microbial or endogenous glycolipid antigens to T cells involved in innate immunity. Natural killer T (NKT) cells and a subpopulation of γδ T cells expressing the Vγ4 T cell receptor (TCR) recognize CD1d. NKT and Vγ4 T cells function in the innate immune response via rapid activation subsequent to infection and secrete large quantities of cytokines that both help control infection and modulate the developing adaptive immune response. T regulatory cells represent one cell population impacted by both NKT and Vγ4 T cells. This review discusses the evidence that NKT cells promote T regulatory cell activation both through direct interaction of NKT cell and dendritic cells and through NKT cell secretion of large amounts of TGFβ, IL-10 and IL-2. Recent studies have shown that CD1d-restricted Vγ4 T cells, in contrast to NKT cells, selectively kill T regulatory cells through a caspase-dependent mechanism. Vγ4 T cell elimination of the T regulatory cell population allows activation of autoimmune CD8+ effector cells leading to severe cardiac injury in a coxsackievirus B3 (CVB3) myocarditis model in mice. CD1d-restricted immunity can therefore lead to either immunosuppression or autoimmunity depending upon the type of innate effector dominating during the infection.

Indexed as

AnimalsAntigens, CD1dAutoimmunityHumansImmune ToleranceNatural Killer T-CellsReceptors, Antigen, T-Cell, gamma-deltaT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAntigens, CD1dReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID21255407
PMCPMC3033358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.